Related Experiment Video
Updated: Jul 8, 2025

07:25
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
13.1K
Talazoparib plus enzalutamide for metastatic castration-resistant prostate cancer: TALAPRO-2 trial
1Department of Urology, AIIMS, New Delhi, India.
Abstract
No abstract available in PubMed .

